Back to UBS Group AG UBS Group AG

NGNENGNE
11 quarters

Position history for UBS Group AGUBS Group AG's holdings in NEUROGENE INC

UBS Group AG holds 171,289 shares of NGNE (NEUROGENE INC), worth $5.4M as of 2026-Q2. The position was decreased (-7.8% shares). NGNE represents 0.0% of UBS Group AG's portfolio.

Current Value

$5.4M

Current Shares

171,289

Total Value Change

+$5.4M

Total Shares Change

+170,289

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
171,289
-7.8%
$5.4M0.0%$31.45
0
2026-Q1
Increased
185,679
+20.5%
$3.7M0.0%$21.99
32
2025-Q4
Decreased
154,123
-32.3%
$3.2M0.0%$22.11
0
2025-Q3
Decreased
227,716
-5.2%
$3.9M0.0%$17.71
0
2025-Q2
Increased
240,319
+15.1%
$3.6M0.0%$16.16
30
2025-Q1
Decreased
208,716
-39.9%
$2.4M0.0%$14.52
0
2024-Q4
Increased
347,201
+6676.0%
$7.9M0.0%$22.28
44
2024-Q3
Increased
5,124
+49.7%
$215,0030.0%$40.33
22
2024-Q2
Decreased
3,423
-64.8%
$124,5630.0%$36.39
0
2024-Q1
Increased
9,718
+871.8%
$494,6470.0%$50.90
39
2023-Q4
New
1,000
-
$19,3800.0%$19.38
29

Other major holders of NGNE: BlackRock Finance, Inc., RTW INVESTMENTS, LP, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used